home

Forbion to step up CNS investment activity after closing €183M fund

EVENTSfiercebiotech2016-04-15 09:10 Read   56

Forbion Capital Partners is set to step up its investment in central nervous system (CNS) biotechs. The European VC shop is committing to the strategy after observing a shift in the economics of CNS drug development, which it thinks makes biotechs in the field a more attractive target for its newly-closed €183 million ($207 million) FCF III fund.

FDA approves folic acid fortification of corn masa flour

RegulatorFDA2016-04-15 08:55 Read   95

The U.S. Food and Drug Administration today approved folic acid fortification of corn masa flour. The approval allows manufacturers to voluntarily add up to 0.7 milligrams of folic acid per pound of corn masa flour, consistent with the levels of certain other enriched cereal grains.

Oculus Innovative Sciences Receives European Approval to Market Sinudox™ Indicated for Use in Nasal Irrigation

EVENTSglobenewswire2016-04-14 15:35 Read   133

Oculus Innovative Sciences, Inc. today announced the issuance of a new CE Mark in Europe for Microcyn®-based Sinudox™ solution, a formulation intended for nasal irrigation including the moistening of cuts, abrasions and lacerations located in the nasal cavity.

Bio Products Laboratory, Ltd Announces FDA Submission of Biologics License Supplement for Gammaplex 10%

R&DBio Products Laboratory2016-04-14 15:23 Read   263

Bio Products Laboratory, Limited (BPL), a leading manufacturer of plasma-derived protein therapies, today announced the submission of a Biologics License Supplement (BLS) to the U.S. Food and Drug Administration (FDA) for the use of Gammaplex 10%, Immune Globulin Intravenous (Human) in patients with primary immunodeficiencies.

Cantabio Pharmaceuticals Announces the Development of Small Molecule Chaperones of the Abeta Peptide for the Treatment of Alzheimer's Disease in Collaboration with NovAliX

Trendglobenewswire2016-04-14 15:23 Read   142

Cantabio Pharmaceuticals Inc. (OTCQB:CTBO) announced today a new preclinical therapeutic program for Alzheimer’s Disease which it is pursuing through its drug discovery partnership with NovAliX.

Senator calls on Medtronic, FDA for bone graft injury data

Regulatorreuters2016-04-14 15:01 Read   121

U.S. Senator Al Franken asked federal regulators and Medtronic Inc for detailed information about injuries associated with the company's bone graft Infuse following a newspaper report that Medtronic hid thousands of adverse events linked to the product.

Brazilian Zika doctors find severe brain damage in babies: study

Frontierreuters2016-04-14 14:57 Read   72

Brazilian scientists studying possible links between birth defects and the mosquito-borne Zika virus have found that babies born with microcephaly have severe brain damage with a range of abnormalities.

Confirmation that Zika causes microcephaly shifts debate to prevention

Healthreuters2016-04-14 14:52 Read   88

After several weeks of study and debate, U.S. health officials concluded that infection with the Zika virus during pregnancy causes the birth defect microcephaly, a finding that experts hope will refocus attention on efforts to stop infections and prompt U.S. lawmakers to fund emergency prevention efforts.

U.S. prescription drug spending to hit $400 billion a year by 2020: IMS

Commentsreuters2016-04-14 14:36 Read   102

U.S. annual spending on prescription medicines will increase 22 percent over the next five years, climbing as high as $400 billion in 2020, according to a report released by health care information company IMS Health Holdings Inc on Thursday.

Long-term weight-loss diet interventions may increase circulating adiponectin

HealthHEALIO2016-04-14 14:28 Read   83

Increases in circulating adiponectin may be found with long-term weight-loss diet interventions with various macronutrient contents, study findings show.

PCV13 vaccine deemed effective in preventing pneumococcal disease

CommentsHEALIO2016-04-14 14:23 Read   60

The majority of pediatric patients who received the 13-valuent pneumococcal conjugate vaccine in this study showed no signs of pneumococcal disease indicated by various serotypes, according to recent research.

Speaker relates what to expect as an expert witness

EVENTSHEALIO2016-04-14 14:19 Read   66

Anyone who engages in expert testimony must know what is meant by standard of care, according to Christie L. Morse, MD, the immediate past chair of the AAO Ethics Committee and executive vice president of AAPOS.